Trypsin liberates an arginine vasopressin-like peptide and neurophysin from a Mr 20,000 putative common precursor. [PDF]
, 1979 J. T. Russell +2 more
openalex +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aim To estimate the impact of semaglutide 2.4 mg treatment on the risk of major adverse cardiovascular events (MACE) in adults with overweight/obesity in the United States based on the SELECT trial of patients with atherosclerotic cardiovascular disease.
Michael G. Nanna +9 more
wiley +1 more source
Increased copeptin may reflect vasopressin-related metabolic changes after bariatric surgery. [PDF]
Obesity (Silver Spring)Galbiati F +7 more
europepmc +1 more source
The Role of Blood Osmolality and Volume in Regulating Vasopressin Secretion in the Rat [PDF]
, 1973 F. L. Dunn +3 more
openalex +1 more source
A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors
Diabetes, Obesity and Metabolism, EarlyView.Abstract The development of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors represents a major turning point in the effort to preserve kidney function and prevent cardiovascular events and heart failure hospitalisations in those at high risk. These agents have now transcended their original glucose‐lowering indication and provide a range of clinical
Daniel Vincent O'Hara, Meg J. Jardine
wiley +1 more source
Comparison between norepinephrine plus epinephrine and norepinephrine plus vasopressin after return of spontaneous circulation in patients with out-of-hospital cardiac arrest. [PDF]
Sci RepAhn S +6 more
europepmc +1 more source
The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. [PDF]
, 1979 Joan T. Crofton +5 more
openalex +1 more source
Evidence for the Release of Vasopressin and Oxytocin into Cerebrospinal Fluid: Measurements in Plasma and CSF of Intact and Hypophysectomized Rats [PDF]
, 1977 J. Dogterom +2 more
openalex +1 more source